×

Growth Reports

Growth Reports
Report Name

Wearable Cardioverter Defibrillator Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Demography (Pediatric, Adults, Geriatric), By End-User (Home, Hospitals and Cardiology Clinics, Others), Countries and Companies Report

Wearable Cardioverter Defibrillator is projected to register a 6.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025154  |   No. of Pages: 205

Warfarin Sensitivity Test Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Instrument, Consumable), By Test (Genetic, Non-genetic), Countries and Companies Report

Warfarin Sensitivity Test is projected to register a 5.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025153  |   No. of Pages: 205

Waldenstrom's Macroglobulinemia Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Plasmapheresis, Targeted therapy, Chemotherapy, Others), Countries and Companies Report

Waldenstrom's Macroglobulinemia Treatment is projected to register a 6.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025152  |   No. of Pages: 205

Vulvodynia Treatment Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Local Anesthetics, Anticonvulsants, Tricyclic Antidepressants, Antimicrobials, Others), By Mode of Administration (Oral, Topical, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), Countries and Companies Report

Vulvodynia Treatment is projected to register a 11.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025151  |   No. of Pages: 205

Vitreoretinal Surgery Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Perfluoro Carbon Liquids, Endoillumination Instruments, Vitreoretinal Prefilled Silicone Oil Syringes, Virectomy System, Others), By Surgery (Anterior Vitreoretinal Surgery, Posterior Vitreoretinal Surgery), Countries and Companies Report

Vitreoretinal Surgery Devices is projected to register a 5.4% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025150  |   No. of Pages: 205

Vision Screeners Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Vision Screening Test, Binocular Testing, Color Vision Testing, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), Countries and Companies Report

Vision Screeners is projected to register a 6.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025149  |   No. of Pages: 205

Virology Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Instruments, Assay Kits and Consumables), By Diagnostic Technique (Molecular Diagnostics Method, Immunoassay-based Method, Mass Spectroscopy-based Method, Others), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Others), Countries and Companies Report

Virology Testing is projected to register a 7.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025146  |   No. of Pages: 205

Viral Vector Manufacturing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Adenoviral Vectors, Aden-associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Others), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Others), By Application (Gene Therapy, Vaccinology), Countries and Companies Report

Viral Vector Manufacturing is projected to register a 13.5% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD00025145  |   No. of Pages: 205